Lori McDermott
Keine laufenden Positionen mehr
Profil
Lori McDermott worked as Vice President-Clinical Development at Scorpius Holdings, Inc. and as Chief Operating Officer at LumaBridge LLC.
She graduated from Drexel University College of Medicine with a graduate degree and from Neumann University with an undergraduate degree.
Ehemalige bekannte Positionen von Lori McDermott
| Unternehmen | Position | Ende |
|---|---|---|
LumaBridge LLC
 LumaBridge LLC BiotechnologyHealth Technology LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle. | Geschäftsführer | 09.08.2023 |
| SCORPIUS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lori McDermott
| Drexel University College of Medicine | Graduate Degree |
| Neumann University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LumaBridge LLC
LumaBridge LLC BiotechnologyHealth Technology LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle. | Health Technology |
